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Commentary (794 words starting from context) 
 
Context 
Propranolol and primidone significantly reduce tremor by around 60% in 50% of 
essential tremor (ET) patients. When medication is ineffective or causes intolerable side 
effects, neurosurgical intervention may be considered. Until recently, radiofrequency 
(RF) ablation or deep brain stimulation (DBS) of the ventralis intermedius (VIM) thalamic 
nucleus were the main surgical options. Gamma knife thalamotomy avoids a burrhole 
but delayed effects make intraoperative validation impossible(1). Recent technical 
advances have enabled transcranial delivery of high-intensity focused ultrasound to 
create a thalamotomy with magnetic resonance imaging (MRI) guidance and real-time 
monitoring. Previous uncontrolled studies suggested that this may be a safe and 
effective alternative for ET patients(2). 
 
Methods 
This randomized controlled trial examined the effect of unilateral focused ultrasound 
thalamotomy or a sham procedure (in a 3:1 ratio) on hand tremor. The primary outcome 
was the between-group difference in hand tremor change from baseline to 3 months 
after intervention as measured with the Clinical Rating Scale for Tremor (CRST). Video 
recordings were rated by independent blinded neurologists. Quality of Life in ET 




Seventy-six patients (71±8 years) were included. The primary outcome was significantly 
different between groups with 47% improvement (18±5 to 10±5) in contralateral hand 
tremor in the active and 0% (16±4 to 16±5) in the sham group (95%CI, 6 to 11; 
P<0.001). This was clinically relevant with 62% vs. 3% reduction in CRST disability 
scores (P<0.001) and 46% vs. 3% reduction in QUEST scores (P<0.001). The 
commonest adverse events were gait disturbance and paraesthesia, each affecting 
around 1/3 of patients. Persistent severe adverse events occurred in 3 of 56 actively 
treated patients (contralateral weakness, dense hypoesthesia and ataxia requiring a 
walker for ambulation).  
 
Commentary 
This well-designed double-blind multicentre trial took full advantage of the ability to 
perform a sham intervention with MRI-guided focused ultrasound. It demonstrated 
significant improvement in contralateral symptoms, disability scores and quality of life. 
No other surgical therapy for ET has been evaluated with such scientific rigour. 
 
Haemorrhage leading to death or disability is a rare complication of DBS and RF 
thalamotomy, although the risk is much less than 1% when employing an image-verified 
approach(3). Patients averse to invasive surgery may consider gamma knife or focused 
ultrasound techniques. The latter requires a full head shave and current technology 
limitations may result in failure to make significant thermal lesions in a proportion of 
patients(4). Although a surgical incision is not required, thalamic lesioning carries a risk 
of persistent neurological deficit. As with other surgical interventions, there was a slight 
decline in symptomatic efficacy over time but without impacting quality of life scores. 
 
DBS for movement disorders was initially popularised by VIM stimulation contralateral to 
a prior RF thalamotomy and was driven by the desire to reduce the high incidence of 
side effects when performing bilateral thalamotomy(5). Thalamic stimulation has fewer 
adverse effects and results in greater functional improvement than RF thalamotomy, 
although tolerance undermines its efficacy advantage after 5 years(6). The main 
advantage of DBS is the potential for bilateral intervention. Nevertheless, hardware 
infection and malfunction may result in therapeutic withdrawal and symptom rebound(7). 
 
Implications for practice 
This study expands the number of surgical therapies available to medically refractory ET 
patients. Future long-term comparative studies may provide further data on relative 
efficacy and side effect profile of these different surgical approaches. However, technical 
limitations, patient preference, local availability and expertise may ultimately determine 
which modality is used in individual patients. 
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